Mink Therapeutics Stock Price Prediction

INKT Stock  USD 0.93  0.06  6.90%   
At this time, the RSI of Mink Therapeutics' share price is approaching 45. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Mink Therapeutics, making its price go up or down.

Oversold Vs Overbought

45

 
Oversold
 
Overbought
Mink Therapeutics stock price prediction is an act of determining the future value of Mink Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Mink Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Mink Therapeutics and does not consider all of the tangible or intangible factors available from Mink Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Mink Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Mink Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.15)
EPS Estimate Current Year
(0.56)
EPS Estimate Next Year
(0.60)
Wall Street Target Price
8
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Mink Therapeutics based on different types of headlines from major news networks to social media. The Mink stock price prediction module provides an analysis of price elasticity to changes in media outlook on Mink Therapeutics over a specific investment horizon. Using Mink Therapeutics hype-based prediction, you can estimate the value of Mink Therapeutics from the perspective of Mink Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Mink Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Mink Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Mink because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Mink Therapeutics after-hype prediction price

    
  USD 0.92  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Mink Therapeutics Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mink Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.142.7710.19
Details
Naive
Forecast
LowNextHigh
0.020.988.40
Details
4 Analysts
Consensus
LowTargetHigh
7.588.339.25
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.17-0.15-0.14
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Mink Therapeutics. Your research has to be compared to or analyzed against Mink Therapeutics' peers to derive any actionable benefits. When done correctly, Mink Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Mink Therapeutics.

Mink Therapeutics After-Hype Price Prediction Density Analysis

As far as predicting the price of Mink Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Mink Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Mink Therapeutics, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Mink Therapeutics Estimiated After-Hype Price Volatility

In the context of predicting Mink Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Mink Therapeutics' historical news coverage. Mink Therapeutics' after-hype downside and upside margins for the prediction period are 0.05 and 8.34, respectively. We have considered Mink Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
0.93
0.92
After-hype Price
8.34
Upside
Mink Therapeutics is dangerous at this time. Analysis and calculation of next after-hype price of Mink Therapeutics is based on 3 months time horizon.

Mink Therapeutics Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Mink Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Mink Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Mink Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.38 
7.42
  0.01 
  0.09 
8 Events / Month
16 Events / Month
In about 8 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
0.93
0.92
1.08 
24,733  
Notes

Mink Therapeutics Hype Timeline

Mink Therapeutics is currently traded for 0.93. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of 0.09. Mink is forecasted to decline in value after the next headline, with the price expected to drop to 0.92. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.08%, whereas the daily expected return is currently at 0.38%. The volatility of related hype on Mink Therapeutics is about 3124.21%, with the expected price after the next announcement by competition of 1.02. About 71.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.65. Mink Therapeutics had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days.
Check out Mink Therapeutics Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.

Mink Therapeutics Related Hype Analysis

Having access to credible news sources related to Mink Therapeutics' direct competition is more important than ever and may enhance your ability to predict Mink Therapeutics' future price movements. Getting to know how Mink Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Mink Therapeutics may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
AFMDAffimed NV(0.03)10 per month 0.00 (0.02) 7.84 (8.79) 28.60 
IMGNImmunoGen(0.1)10 per month 0.70  0.12  5.69 (1.50) 84.35 
ADAPAdaptimmune Therapeutics Plc(0.02)8 per month 5.23  0.11  12.87 (9.09) 31.05 
SGMOSangamo Therapeutics(0.06)8 per month 8.03  0.07  18.29 (11.29) 69.94 
DAWNDay One Biopharmaceuticals 0.63 9 per month 4.41  0.03  6.30 (8.71) 24.09 
ABOSAcumen Pharmaceuticals 0.1 7 per month 3.87 (0.01) 7.28 (5.98) 23.58 
XFORX4 Pharmaceuticals 0.16 9 per month 4.97  0.13  10.47 (9.09) 40.83 
INZYInozyme PharmaInc(0.35)8 per month 4.39  0  8.83 (8.42) 25.32 
VECTVectivBio Holding AG 0.06 7 per month 0.88  0.20  5.61 (3.08) 39.30 
TERNTerns Pharmaceuticals(0.27)7 per month 5.24 (0.02) 8.64 (8.38) 27.76 
HOOKHookipa Pharma 0.01 10 per month 3.20  0.07  9.88 (6.17) 24.40 
KAKineta Inc 0.08 8 per month 0.00 (0.11) 16.33 (18.18) 72.56 
CADLCandel Therapeutics 4.37 8 per month 4.07  0.14  13.49 (8.52) 301.79 
FBRXForte Biosciences 0.01 6 per month 4.76  0.02  7.94 (6.41) 29.50 
ALVRAllovirInc(0.05)7 per month 2.65  0.07  6.67 (4.05) 17.33 
GLUEMonte Rosa Therapeutics 0.59 8 per month 7.04  0.01  10.84 (9.52) 38.28 
DSGNDesign Therapeutics(0.01)9 per month 2.99  0.17  9.52 (5.08) 22.48 
HOWLWerewolf Therapeutics 0.28 10 per month 4.48  0.14  12.20 (7.50) 33.25 
IKNAIkena Oncology 0.04 6 per month 0.00 (0.03) 7.53 (6.16) 23.04 
STOKStoke Therapeutics(0.69)8 per month 4.71  0.17  22.86 (8.17) 64.95 

Mink Therapeutics Additional Predictive Modules

Most predictive techniques to examine Mink price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Mink using various technical indicators. When you analyze Mink charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Mink Therapeutics Predictive Indicators

The successful prediction of Mink Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Mink Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Mink Therapeutics based on analysis of Mink Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Mink Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Mink Therapeutics's related companies.
 2021 2023 2024 (projected)
Payables Turnover9.5K0.05230.0497
Days Of Inventory On Hand2.3E-52.6E-52.5E-5

Story Coverage note for Mink Therapeutics

The number of cover stories for Mink Therapeutics depends on current market conditions and Mink Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Mink Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Mink Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Mink Therapeutics Short Properties

Mink Therapeutics' future price predictability will typically decrease when Mink Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Mink Therapeutics often depends not only on the future outlook of the potential Mink Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Mink Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding34.4 M
Cash And Short Term Investments3.4 M
When determining whether Mink Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Mink Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Mink Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Mink Therapeutics Stock:
Check out Mink Therapeutics Basic Forecasting Models to cross-verify your projections.
For more information on how to buy Mink Stock please use our How to Invest in Mink Therapeutics guide.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Complementary Tools for Mink Stock analysis

When running Mink Therapeutics' price analysis, check to measure Mink Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mink Therapeutics is operating at the current time. Most of Mink Therapeutics' value examination focuses on studying past and present price action to predict the probability of Mink Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mink Therapeutics' price. Additionally, you may evaluate how the addition of Mink Therapeutics to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Is Mink Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mink Therapeutics. If investors know Mink will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mink Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.65)
Return On Assets
(1.10)
Return On Equity
(12.39)
The market value of Mink Therapeutics is measured differently than its book value, which is the value of Mink that is recorded on the company's balance sheet. Investors also form their own opinion of Mink Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Mink Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mink Therapeutics' market value can be influenced by many factors that don't directly affect Mink Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mink Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Mink Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mink Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.